Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling
出版年份 2013 全文链接
标题
Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 110, Issue 2, Pages 341-352
出版商
Springer Nature
发表日期
2013-12-04
DOI
10.1038/bjc.2013.752
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mechanisms of Gambogic Acid-Induced Apoptosis in Non-Small Cell Lung Cancer Cells in Relation to Transferrin Receptors
- (2014) Xiaoli Zhu et al. JOURNAL OF CHEMOTHERAPY
- Gambogic Acid as a Non-Competitive Inhibitor of ATP-Binding Cassette Transporter B1 Reverses the Multidrug Resistance of Human Epithelial Cancers by Promoting ATP-Binding Cassette Transporter B1 Protein Degradation
- (2013) Xu Wang et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Viability inhibition effect of gambogic acid combined with cisplatin on osteosarcoma cells via mitochondria-independent apoptotic pathway
- (2013) Wei Zhao et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Smad7 sensitizes A549 lung cancer cells to cisplatin-induced apoptosis through heme oxygenase-1 inhibition
- (2012) Woo-Kwang Jeon et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Gambogic acid promotes apoptosis and resistance to metastatic potential in MDA-MB-231 human breast carcinoma cells
- (2012) Chenglin Li et al. Biochemistry and Cell Biology
- Heme Oxygenase-1 in Lung Disease
- (2012) Chintan M. Raval et al. CURRENT DRUG TARGETS
- Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data
- (2012) María S. Degese et al. LUNG CANCER
- Caspase Substrates and Cellular Remodeling
- (2011) Emily D. Crawford et al. Annual Review of Biochemistry
- GDC-0941 sensitizes breast cancer to ABT-737 in vitro and in vivo through promoting the degradation of Mcl-1
- (2011) Lin Zheng et al. CANCER LETTERS
- Are there new therapeutic options for treating lung cancer based on herbal medicines and their metabolites?
- (2011) Soo-Jin Jeong et al. JOURNAL OF ETHNOPHARMACOLOGY
- Selective killing of cancer cells by a small molecule targeting the stress response to ROS
- (2011) Lakshmi Raj et al. NATURE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Herbal therapy use by cancer patients: A literature review on case reports
- (2010) Oluwadamilola Olaku et al. EUROPEAN JOURNAL OF CANCER
- NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target
- (2010) Wenshu Chen Frontiers in Bioscience-Landmark
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
- (2010) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: A systematic review
- (2009) Sisi Chen et al. LUNG CANCER
- Reactive oxygen species accumulation contributes to gambogic acid-induced apoptosis in human hepatoma SMMC-7721 cells
- (2009) Feifei Nie et al. TOXICOLOGY
- Suppression of Nrf2-driven heme oxygenase-1 enhances the chemosensitivity of lung cancer A549 cells toward cisplatin
- (2007) Hak-Ryul Kim et al. LUNG CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started